Affiliation:
1. , Nashik, Maharashtra, India
Abstract
On a worldwide scale, the diabetic retinopathy (DR) is listing the primary causes of the loss of sight in the individuals. The main reason behind the occurrence of DR is diabetes mellitus (DM) and diabetic macular edema (DME). Diabetic retinopathy have some types of it i.e Non- proliferative diabetic retinopathy (NPDR) and Proliferative diabetic retinopathy (PDR). Where NPDR is an initial stage and PDR is the severe stage where the person loss the eye sight due to various factors which causes changes in the retinal micro vascularisation. Use of Curcumin in Diabetic Retinopathy may help as a treatment and preventive action for all the stages of DR with its active constituent in various ways. We are focusing on some highlights of curcumin as an active drug to prevent and management of the DR. As the given review presenting the versatility of natural source of medicine like a curcumin can be the best choice of drug for diabetic retinopathy due to its various effects like protect the loss of retinal ganglionic cells, neuroprotective effect by inhibiting oxidative damage to microglia, also act as anti- inflammatory agent, anti VEGF agent, a recognized PPAR-gamma agonist. Hence, In future Curcumin can be preferably useful for management of all the stages involved in Diabetic Retinopathy.
Publisher
IP Innovative Publication Pvt Ltd
Reference26 articles.
1. El-Asrar AM Abu, Al-Mezaine HS, Pathophysiology and management of diabetic retinopathy.Expert Rev Ophthalmol 2009;4(6):627-47
2. Nutraceuticals for the Treatment of Diabetic Retinopathy
3. Gologorsky D, Thanos A, Vavvas D, Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy..Mediators of Inf.629452
4. Das A, Stroud S, Mehta A, Rangasamy S, New treatments for diabetic retinopathy..Diab Obesity Metab 2015;17:219-49
5. Filippelli M, Campagna G, Vito P, Zotti T, Ventre L, Rinaldi M, Anti-inflammatory effect of curcumin, homotaurine, and vitamin D3 on human vitreous in patients with diabetic retinopathy.Front Neurosci 2021;11:592274